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Reverse Cholesterol Transport 
a potential therapeutic target for atherosclerosis 
1. Both ABCA1 and SR-BI are essential for HDL-mediated reverse cholesterol transport 
(this thesis). 
2. ABCA1-mediated HDL biogenesis is atherogenic when hepatic SR-BI is absent (this 
thesis). 
3. The synergistic interaction of macrophage ABCA1 and SR-BI are more important for 
prevention of advanced atherosclerotic lesions rather than for the development of 
early atherosclerotic lesions (this thesis). 
4. The expression of the LDL receptor is not required for the atheroprotective function 
of leukocyte ABCA1 (this thesis). 
5. The beneficial effects of reconstituted HDL on atherosclerotic lesion development are 
partially caused by its phosphatidylcholine component (this thesis). 
6. Hepatic SR-BI determines the atheroprotective effects of HDL elevation by inducing 
overexpression of ABCA1 in liver (Feng Y, Cardiovasc Res. 2010; 88: 376-85). 
7. The cholesterol efflux capacity of HDL does not necessarily reflect the 
atheroprotective efficiency of HDL (Undurti A, J Biol Chem. 2009; 284: 30825-35). 
8. Intracellular trafficking of free cholesterol not only influences cellular cholesterol 
homeostasis but also plays an important role in cell signaling pathways linked to cell 
function (Yvan-Charvet L, Science. 2010; 328: 1689-93; Koseki M, J Lipid Res. 
2007; 48: 299-306). 
9. The suppressive function of SR-BI in leukocyte proliferation contributes to its anti-
atherogenic effects (Feng H, Arterioscler Thromb Vasc Biol. 2011; in press). 
10. Stress should be prevented at all times as it leads to the waste of energy and 
distraction of attention. 
11. After becoming a mother, you have to be efficient in your scientific work in order to 
reach home in time. 
12. Good social collaboration skills are important for a successful scientific career. 
13. Fighting with the reviewer inspires your research and improves the quality of your 
paper. 
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